RxDoctor Payments Data

Dorothy Milburn

Family · Braymer, MONPI 1477520690

Payments from drug & device makers

$2,890in general payments, 2019–2025

Across 170 payments — averaging $17.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$824
  • Lilly USA, LLC$363
  • Lundbeck LLC$218
  • AstraZeneca$196
  • Mylan Specialty L.p.$181
  • Novo Nordisk$159
  • plus $949 from 20 others

What the payments were for

  • Food & beverage$2,890100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,890 in reported general payments places this provider in the 85th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide96$112,123
TrulicityDulaglutide69$77,295
EliquisApixaban91$69,375
OzempicSemaglutide31$48,106
Breztri AerosphereBudesonide/Glycopyr/Formoterol41$30,945
JanuviaSitagliptin Phosphate27$27,163
XareltoRivaroxaban29$21,088
RexultiBrexpiprazole14$20,285
EntrestoSacubitril/Valsartan21$17,411
LinzessLinaclotide28$17,206
JanumetSitagliptin Phos/Metformin Hcl16$13,948
FarxigaDapagliflozin Propanediol13$13,155
MyrbetriqMirabegron21$10,970
RybelsusSemaglutide11$10,438
SymbicortBudesonide/Formoterol Fumarate31$8,102

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$363$189,418165 claims
PfizerEliquis, Premarin$120$72,474105 claims
Novo NordiskOzempic, Rybelsus$159$58,54442 claims
AstraZenecaBreztri Aerosphere, Farxiga, Symbicort$196$52,20285 claims
MerckJanuvia, Janumet, Dulera$93$47,95655 claims
Johnson & JohnsonXarelto$33$21,08829 claims
Otsuka America Pharmaceutical, Inc.Rexulti$56$20,28514 claims
AbbVieLinzess, Synthroid$824$19,43476 claims
Astellas Pharma US IncMyrbetriq$20$10,97021 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,812 family providers in Missouri.

Other family in Braymer

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →